Back
Sarepta Therapeutics Vs. FirstCash Holdings Industry Stock Comparison
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
135.00
Seasonality Move:
16.32%
Buy
58
FCFS
FirstCash Holdings
Last Price:
116.64
Seasonality Move:
5.12%
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.66. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
FirstCash Holdings (FCFS)
is a Buy
Is FirstCash Holdings a Buy, Sell or Hold?
- The current FirstCash Holdings [FCFS] share price is $116.35. The Score for FCFS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- FCFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCFS Stock Price Chart
What is FirstCash Holdings's stock price today?
-
The FirstCash Holdings share price today is $116.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCFS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 67.1 | Buy |
| Chaikin Money Flow: | 612520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.36 - 129.54) | Buy |
| Bollinger Bands (100): | (105.79 - 132.01) | Buy |
FCFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.36 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | 137215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.02 - 131.26) | Sell |
| Bollinger Bands (100): | (110.6 - 124.14) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.85 | Buy |
| 20-day SMA: | 123.86 | Buy |
| 50-day SMA: | 125.76 | Buy |
| 200-day SMA: | 112.16 | Buy |
| 8-day EMA: | 128.57 | Buy |
| 20-day EMA: | 125.83 | Buy |
| 50-day EMA: | 124.03 | Buy |
| 200-day EMA: | 116.7 | Buy |
FCFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.07 | Sell |
| 20-day SMA: | 124.7 | Sell |
| 50-day SMA: | 121.62 | Sell |
| 200-day SMA: | 109.09 | Buy |
| 8-day EMA: | 117.77 | Sell |
| 20-day EMA: | 121.51 | Sell |
| 50-day EMA: | 121.31 | Sell |
| 200-day EMA: | 111.35 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.82 per share, an increase next quarter of $1.55 per share, an increase this year of $5.41 per share, and an increase next year of $6.16 per share.
FirstCash Holdings Earnings Growth & FCFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.05 per share, and an increase next year of $1.23 per share.
Sarepta Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FirstCash Holdings Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||